← Browse by Condition
Medical Condition

her2 negative breast cancer brain metastases

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06418594 Phase 2
Recruiting

Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis

Enrollment
30 pts
Location
China
Sponsor
Beijing 302 Hospital
View Trial →